Evidence map›Paper›PMID 28455995›Full record

ArticleMedical science monitor : international medical journal of experimental and clinical research2017

Boschniakia Rossica Polysaccharide Triggers Laryngeal Carcinoma Cell Apoptosis by Regulating Expression of Bcl-2, Caspase-3, and P53.

Chunping Yao, Xiujuan Cao, Zheng Fu, Jing Tian, Wei Dong, Jin Xu, Kang An, Limin Zhai, Jinming Yu

RetractedOpen access · hybridAbstract readRetracted Publication
In one paragraph

Article in Medical science monitor : international medical journal of experimental and clinical research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Review
  3. Retracted: Boschniakia rossica Polysaccharide Triggers Laryngeal Carcinoma Cell Apoptosis by Regulating Expression of Bcl-2, Caspase-3, and P53.Medical science monitor : international medical journal of experimental and clinical research · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. International journal of molecular sciences · 2020
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Escins Isolated fromFrontiers in pharmacology · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Chunping YaoDepartment of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China (mainland).
Xiujuan CaoDepartment of Radiation Oncology, Shandong Cancer Hospital Affiliated with Shandong University, Shandong Academy of Medical Science, Jinan, Shandong, China (mainland).
Zheng FuPET-CT Center, Shandong Cancer Hospital Affiliated with Shandong University, Shandong Academy of Medical Science, Jinan, Shandong, China (mainland).
Jing TianDepartment of Medical Oncology, Shandong Cancer Hospital Affiliated with Shandong University, Shandong Academy of Medical Science, Jinan, Shandong, China (mainland).
Wei DongDepartment of Radiation Oncology, Shandong Cancer Hospital Affiliated with Shandong University, Shandong Academy of Medical Science, Jinan, Shandong, China (mainland).
Jin XuDepartment of Radiation Oncology, Shandong Cancer Hospital Affiliated with Shandong University, Shandong Academy of Medical Science, Jinan, Shandong, China (mainland).
Kang AnSecond Internal Medical Department, Zibo Zhoucun Renmin Hospital, Zibo, Shandong, China (mainland).
Limin ZhaiDepartment of Radiation Oncology, Shandong Cancer Hospital Affiliated with Shandong University, Shandong Academy of Medical Science, Jinan, Shandong, China (mainland).
Jinming YuDepartment of Radiation Oncology, Shandong Cancer Hospital Affiliated with Shandong University, Shandong Academy of Medical Science, Jinan, Shandong, China (mainland).
Shandong Tumor Hospital · CNShandong First Medical University · CNTianjin Medical University Cancer Institute and Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Laryngeal cancer is a malignant head and neck tumor with high morbidity and high mortality in humans. Recently, treatments with Chinese medicines and their extracts have gradually received great attention, and studies suggest that Boschniakia rossica polysaccharide (BRP) has potential anti-tumor activity. Therefore, this study investigating the role of BRP in inducing apoptosis in human laryngeal carcinoma cells. MATERIAL AND METHODS The BRP was extracted with organic solvent and HR column. We treated Hep2 laryngeal carcinoma cells with different concentrations of BRP, then assessed cell growth inhibition rate by flow cytometry and apoptosis index by TUNEL staining. The protein expression of p53, Bcl-2, Bax, and caspase-3 were analyzed by Western blot. RESULTS Flow cytometry results showed that BRP inhibited Hep2 cell proliferation in a dose-dependent manner (p<0.05), and TUNEL staining indicated that BRP significantly increased Hep2 apoptosis index (p<0.05). Western blot results showed that the expression levels of p53 and activation of caspase-3 in Hep2 cells were significantly up-regulated (p<0.05), while the expression of Bcl-2 was significantly down-regulated (p<0.05). CONCLUSIONS BRP might induce cell apoptosis by regulating the expression level of cell apoptosis-associated proteins, suggesting strong anti-laryngeal cancer activity.

Indexed as

ApoptosisCaspase 3Cell Line, TumorCell ProliferationGenes, bcl-2HumansLaryngeal NeoplasmsLarynxMedicine, Chinese TraditionalOrobanchaceaePolysaccharidesTumor Suppressor Protein p53Caspase 3PolysaccharidesTumor Suppressor Protein p53

Identifiers

PMID28455995
PMCPMC5421584
OpenAlexW2608427804

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.